Table 2.
Patients’ Main Clinical and Laboratory Characteristics.
| n (%) | |
|---|---|
| Disease subset lcSSc/dcSSc | 23 (56.1) / 18 (43.9) |
| Serological specificities | |
| Negative | 10 (24.4) |
| Anti-centromere negative/positive | 14 (34.1) / 17 (41.5) |
| Anti-Scl70 negative/positive | 16 (39) / 15 (36.6) |
| Comorbidities | |
| ILD | 11 (26.8) |
| ILD score (mean ± SD)(range) | 3.63 ± 3.84 (0 – 16) |
| PAH | 4 (9.8) |
| Medical treatment | |
| Corticosteroid negative/positive | 17 (41.5) / 24 (58.5) |
| Immunosuppressive negative/positive | 19 (46.3) / 22 (53.7) |
| Patient follow up duration (years) | |
| (mean ± SD)(range) | 10.70 ± 4.49 (5 – 18) |
lcSSc: limited systemic sclerosis, dcSSc: diffuse systemic sclerosis, ILD: interstitial lung disease, SD: standard deviation.